esophageal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with esophageal cancer who are hospitalized or attending the Department of Gastroenterology and General Surgery, Showa University Hospital, and who have undergone radical thoracoscopic subtotal esophagectomy 2) Patients whose age at the time of consent acquisition is between 20 and 75 years old. 3) Patients who have given written consent to participate in this study.
Exclusion criteria
Exclusion criteria: (1) Patients with contraindications to the administration of levobupivacaine, fentanyl, or acetaminophen. (2) Patients who are at risk for epidural anesthesia catheter insertion or who have difficulty in insertion. (3) Patients who have difficulty in interviewing for postoperative pain assessment (dementia, postoperative intubation status, etc.). (4) Patients with serious hepatic, renal, or cardiac disorders that may affect the safety assessment of the drug. 5) Patients with additional painful procedures such as insertion of additional thoracic drains in the postoperative course, or with postoperative complications that affect postoperative pain. (6) Patients who have been administered anticoagulants before surgery. (7) Patients deemed ineligible by the research physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numerical Rating Scale (NRS) at postoperative day 1 and 3 and 5. | — |
Countries
Japan
Contacts
SHOWA University General and Gastroenterological Surgery